好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Platelet to Lymphocyte Ratio and its Role in Monophasic Idiopathic Transverse Myelitis: A Multicenter Study
Autoimmune Neurology
P1 - Poster Session 1 (11:45 AM-12:45 PM)
8-014

To examine the relationship between Platelet to Lymphocyte Ratio (PLR) at onset and risk of severe disability from an attack of monophasic Idiopathic Transverse Myelitis (ITM) and the relationship of PLR to relapse and disability among double seronegative Neuromyelitis Optica Spectrum Disorder (DSN-NMOSD) patients.

ITM is a monophasic neurological inflammatory attack of the spinal cord that is not associated with any infections, metabolic or vascular anomalies, or spinal cord compression.

This is a retrospective study on monophasic ITM and DSN-NMOSD cases at MassGeneralBrigham Hospitals. Spearman correlation analysis and linear regression analyses were conducted to evaluate the relationships between log-transformed PLR and Expanded Disability Status Scale (EDSS). Logistic regression analyses were also conducted to assess whether log-transformed PLR is associated with severe disability defined by an EDSS ≥ 4. Finally, logistic regression analyses were performed to assess whether log-transformed PLR is associated with relapse risk and EDSS ≥ 4 or ≥ 6 between monophasic ITM and DSN-NMOSD.

A total of 46 monophasic ITM patients was divided into low (<137) and high (≥137) PLR based on the calculated median PLR. Correlation analysis showed a positive association between EDSS and log-transformed PLR (Spearman’s ρ=0.299,p=0.043). Linear regression analyses between log PLR and EDSS showed no significant association (β = 0.35, 95% CI -0.72.-1.42,p=0.512). In both logistic regression analyses, log-transformed PLR did not show significant association with severe disability (univariate OR= 2.59, 95% CI 0.65-12.25,p=0.196; multivariate OR=1.44, 95%CI 0.24-9.06,p=0.690). Furthermore, logistic regression analyses of relapsing DSN-NMOSD cases showed that log-transformed PLR was not associated with risk of relapse and EDSS level of ≥ 4 or  ≥ 6.

In monophasic ITM, while PLR at onset and EDSS are correlated, PLR did not associate with risk of severe disability, contrary to previous studies. Among DSN-NMOSD cases, PLR was not associated with either relapse risk or disability.

Authors/Disclosures
Gerome B. Vallejos, MD
PRESENTER
Mr. Vallejos has nothing to disclose.
Joao Vitor Mahler, MD Dr. Mahler has received research support from The Sumaira Foundation.
Takahisa Mikami, MD (Massachusetts General Hospital) Dr. Mikami has nothing to disclose.
Michael Levy, MD, PhD, FAAN (Massachusetts General Hospital/Harvard Medical School) Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Levy has received research support from National Institutes Health.